Clinical Trial Update: Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Kanglaite Injection (KLTi) in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Kanglaite Injection (Kanglaite)

Snippet

Sponsor: Jie Li | Conditions: NSCLC | Phase 4 | Status: UNKNOWN